Terms ending in 2034
Every in-force patent on Vesalio, Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,900,265 | Clot Retrieval System In force · High confidence | Vesalio, Inc. | In force | High confidence | |
| US 9,155,552 | Clot Retrieval System In force · High confidence | Vesalio, Inc. | In force | High confidence | |
| US 9,173,668 | Clot Retrieval System In force · High confidence | Vesalio, Inc. | In force | High confidence | |
| US 9,566,412 | Method of Manufacturing a Catheter-Delivered Medical Device from a Tube In force · High confidence | Vesalio, Inc. | In force | High confidence | |
| US 9,801,644 | Clot Retrieval System In force · High confidence | Vesalio, Inc. | In force | High confidence | |
| US 9,808,271 | Clot Retrieval System In force · High confidence | Vesalio, Inc. | In force | High confidence | |
| US 9,814,478 | Clot Retrieval System In force · High confidence | Vesalio, Inc. | In force | High confidence | |
| US 9,820,764 | Clot Retrieval System In force · High confidence | Vesalio, Inc. | In force | High confidence | |
| US 9,826,998 | Clot Retrieval System In force · High confidence | Vesalio, Inc. | In force | High confidence | |
| US 9,833,253 | Clot Retrieval System In force · High confidence | Vesalio, Inc. | In force | High confidence | |
| 19 more term ends in 2034 · Pro | |||||
10 of 29 patents shown. Soonest term end first, then patent number.
Pro members see all 29.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.